According to NRx Pharmaceuticals's latest financial reports the company has $4.59 M in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2022-12-31 | $20.05 M | -27.35% |
2021-12-31 | $27.6 M | 1384.94% |
2020-12-31 | $1.85 M |